Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Copolymer 1 in Relapsing-Remitting Multiple Sclerosis
NCT00004814Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Oct 1991
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Copolymer 1 with Placebo (2 arms). Primary endpoint: Mean Number of Relapses at 2 years. Started Oct 1991; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00004814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004814.